Jump to Content
Jump to Main Navigation
User Account
Sign In
to save searches and organize your favorite content.
Not registered?
Sign up
My Content
(0)
Searches
(0)
More
Subscriptions
Join E-mail List
Help
JNCCN
Menu
Home
Content
Current Issue
Past Issues
Online First
Supplements
NCCN Meeting Highlights
JNCCN In the News
COVID-19
CE
JNCCN 360
Author Center
Call for Papers
Submit a Manuscript
Information for Authors
Reprints/Permissions
About
JNCCN
Editorial Board
Editorial Calendar
NCCN
Harborside
Search
Close
Advanced Search
Help
QIM21-093: Guideline and Standard Development for Medically Integrated Dispensing Pharmacies for Oral Anticancer Medication: ASCO/NCODA Standards
Authors:
Josh Nubla
PharmD
1
,
Ginger Blackmon
PharmD
1
and
Austin Starkey
PharmD
1
View More
View Less
1
National Community Oncology Dispensing Association (NCODA), Cazenovia, NY
Volume/Issue:
Volume 19: Issue 3.5
Online Publication Date:
17 Mar 2021
DOI:
https://doi.org/10.6004/jnccn.2020.7784
Restricted access
Purchase article (
USD
$0.01
)
Citation Alert
Get Permissions
Article Details
Corresponding Author: Josh Nubla, PharmD
Print
Collapse
Expand
Top
Article Information
Copyright:
Copyright © 2021 by the National Comprehensive Cancer Network 2021
Page Numbers:
QIM21-093
Article Category:
Abstract
Print Publication Date:
20 Mar 2021
Online Publication Date:
17 Mar 2021
Citation Alert
Get Permissions
PubMed
Article by Josh Nubla
Article by Ginger Blackmon
Article by Austin Starkey
Google Scholar
Article by Josh Nubla
Article by Ginger Blackmon
Article by Austin Starkey
Similar articles in Google Scholar
Related Articles
Metrics
All Time
Past Year
Past 30 Days
Abstract Views
0
0
0
Full Text Views
49
49
17
PDF Downloads
112
112
21
EPUB Downloads
0
0
0
[18.206.177.17]
18.206.177.17
Sign in to annotate
Close
Edit
Character limit
500
/500
Delete
Cancel
Save
@!
Character limit
500
/500
Cancel
Save